Cardiovascular Ion Channel Inhibitor Drug-Drug Interactions with P-glycoprotein
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmaceutical Science
Link
http://link.springer.com/content/pdf/10.1208/s12248-016-0023-y.pdf
Reference126 articles.
1. Kantor ED, Rehm CD, Haas JS, Chan AT, Giovannucci EL. Trends in prescription drug use among adults in the United States from 1999–2012. JAMA. 2015;314(17):1818–30. doi: 10.1001/jama.2015.13766 .
2. Zaidenstein R, Eyal S, Efrati S, Akivison L, Michowitz MK, Nagornov V, et al. Adverse drug events in hospitalized patients treated with cardiovascular drugs and anticoagulants. Pharmacoepidemiol Drug Saf. 2002;11(3):235–8. doi: 10.1002/pds.693 .
3. Tabrizchi R. Molecular mechanisms of adverse drug reactions in cardiac tissue. Handb Exp Pharmacol. 2010;196:77–109. doi: 10.1007/978-3-642-00663-0_4 .
4. Gholami K, Ziaie S, Shalviri G. Adverse drug reactions induced by cardiovascular drugs in outpatients. Pharm Pract (Granada). 2008;6(1):51–5.
5. Mowry JB, Spyker DA, Brooks DE, McMillan N, Schauben JL. Annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 32nd annual report. Clin Toxicol (Phila). 2015;53(10):962–1147. doi: 10.3109/15563650.2015.1102927 . 2014.
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Interplay Between Molecular Architecture, Pharmacology, and Suspected Adverse Drug Reactions Associated with Non-Steroidal Androgen Antagonists in The United Kingdom;2024-07-09
2. Poor Correlation of Rivaroxaban Concentration with the Routine Coagulation Screening Test in Chinese Patients with Atrial Fibrillation;Journal of Clinical Pharmacy and Therapeutics;2023-10-31
3. Expression and Pharmaceutical Relevance of Intestinal Transporters;Oral Bioavailability and Drug Delivery;2023-10-10
4. Risk for Bleeding-Related Hospitalizations During Use of Amiodarone With Apixaban or Rivaroxaban in Patients With Atrial Fibrillation;Annals of Internal Medicine;2023-06
5. The Alternating Access Mechanism in Mammalian Multidrug Resistance Transporters and Their Bacterial Homologs;Membranes;2023-05-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3